Bácskay Ildikó

1.

Bíró, K., Révész, R., Pető, Á., Kósa, D., Buchholcz, G., Gyöngyösi, A., Lekli, I., Nemes, D., Bácskay, I., Haimhoffer, Á., Ujhelyi, Z.: Application of new types of surfactants for the development of an adjuvant containing squalene by ultrasonic production.
Tenside Surfactants Deterg. 1, 1-10, 2026.

doi DEA WoS Scopus

Journal metrics:

Q3 Chemical Engineering (miscellaneous) (2025)

Q3 Chemistry (miscellaneous) (2025)

Q3 Condensed Matter Physics (2025)

2.

Révész, R., Mengenli, A. D., Dossi, E., Alsheikh, R., Nemes, D., Ujhelyi, Z., Pető, Á., Rusznyák, Á., Sipos, É., Gyöngyösi, A., Lekli, I., Bácskay, I., Fenyvesi, F., Haimhoffer, Á.: Cyclodextrin Polymer Complexation Improves the Tolerability of Parenteral Oestradiol.
Pharmaceutics. 18 (2), 1-18, (article identifier: 247), 2026.

doi DEA WoS Scopus

Journal metrics:

D1 Pharmaceutical Science (2025)

3.

Fésüs, A., Szilágyi, Z., Beniczky, Z., Varga, E., Matuz, M., Gaál, K., Somodi, S., Bácskay, I., Lekli, I., Vaskó, A.: Evaluation of Antibiotic Use in Patients Admitted to a Hungarian Intensive Care Unit with Pneumonia and Sepsis: retrospective Observational Before-After Study.
Antibiotics. 15 (3), 1-21, (article identifier: 252), 2026.

doi DEA

Journal metrics:

Q1 Biochemistry (2025)

Q1 Infectious Diseases (2025)

Q1 Microbiology (2025)

Q1 Microbiology (medical) (2025)

Q1 Pharmacology (medical) (2025)

D1 Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (2025)

4.

Balogh, B. N., Klusóczki, Á., Pető, Á., Fehér, P., Ujhelyi, Z., Váradi, J., Bácskay, I.: In Vitro Investigation of Tapinarof-Loaded Nanogels in an Imiquimod-induced HaCaT-THP-1 Co-Culture Model.
Eur. J. Pharm. Sci. 221, 1-15, (article identifier: 107510), 2026.

doi DEA

Journal metrics:

Q1 Pharmaceutical Science (2025)

5.

Papp, B., Szűcs, Z., Gonda, S., Cziáky, Z., Kajtár, R., Lekli, I., Haimhoffer, Á., Klusóczki, Á., Józsa, L., Pető, Á., Normakhamatov, N. S., Ujhelyi, Z., Bácskay, I., Fehér, P.: Preparation and Investigation of Artemisia annua L.-Loaded Alginate Hydrogels with Excipients.
Pharmaceuticals. 19 (3), 1-27, (article identifier: 424), 2026.

doi DEA

Journal metrics:

Q1 Drug Discovery (2025)

Q2 Molecular Medicine (2025)

Q1 Pharmaceutical Science (2025)

6.

Alsheikh, R., Nemes, D., Fehér, P., Ujhelyi, Z., Haimhoffer, Á., Papp, Á., Bácskay, I.: Thermosensitive in situ gels for ocular drug delivery: advances in polymer-based formulations.
Eur. J. Pharm. Sci. 218, 1-14, (article identifier: 107439), 2026.

doi DEA

Journal metrics:

Q1 Pharmaceutical Science (2025)

7.

Lakatos, I., Bogacsovics, G., Tiba, A., Priksz, D., Juhász, B., Erdélyi, R., Berényi, Z., Bácskay, I., Ujvárosy, D., Harangi, B.: AI-Driven Framework for Enhanced and Automated Behavioral Analysis in Morris Water Maze Studies.
Sensors. 25, 1-16, (article identifier: 1564), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Analytical Chemistry

Q2 Atomic and Molecular Physics, and Optics

Q2 Biochemistry

Q1 Electrical and Electronic Engineering

Q2 Information Systems

Q1 Instrumentation

Q2 Medicine (miscellaneous)

8.

Bácskay, I., Arany, P., Fehér, P., Józsa, L., Vasvári, G., Nemes, D., Pető, Á., Kósa, D., Haimhoffer, Á., Ujhelyi, Z., Sinka, D. Z.: Bioavailability Enhancement and Formulation Technologies of Oral Mucosal Dosage Forms: a Review.
Pharmaceutics. 17 (2), 1-19, (article identifier: 148), 2025.

doi DEA WoS Scopus

Journal metrics:

D1 Pharmaceutical Science

9.

Csendes, O., Vasvári, G., Haimhoffer, Á., Horváth, L., Béres, M., Bényei, A., Bácskay, I., Fehér, P., Ujhelyi, Z., Nemes, D.: Bioavailability Enhancement of Curcumin by PEG-Based Gastroretentive System: development and In Vitro Evaluation.
Pharmaceutics. 17 (9), 1-24, (article identifier: 1166), 2025.

doi DEA

Journal metrics:

D1 Pharmaceutical Science

10.

Fenyvesi, F., Klusóczki, Á., Rusznyák, Á., Zsebik, B., Bácskay, I., Váradi, J.: Cyclodextrin-Based Delivery Systems for Flavonoids: Mechanisms, Advances, Formulation, and Application Opportunities.
Antioxidants. 14 (8), 998-, 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry

Q1 Cell Biology

Q1 Clinical Biochemistry

D1 Food Science

Q1 Molecular Biology

Q1 Physiology

11.

Bodnár, K., Papp, B., Sinka, D. Z., Fehér, P., Ujhelyi, Z., Lekli, I., Kajtár, R., Nacsa, F., Bácskay, I., Józsa, L.: Development of Salvia officinalis-Based Self-Emulsifying Systems for Dermal Application: antioxidant, Anti-Inflammatory, and Skin Penetration Enhancement.
Pharmaceutics. 17 (2), 1-25, (article identifier: 140), 2025.

doi DEA

Journal metrics:

D1 Pharmaceutical Science

12.

Hohmann, J., Szökő, É., Tábi, T., Bácskay, I.: Editorial: CPH-EUFEPS 2024 Special Issue.
Eur. J. Pharm. Sci. 214, 1-2, (article identifier: 107270), 2025.

doi DEA Scopus

13.

Varga, E., Somodi, S., Molnár, M., Ujvárosy, D., Gaál, K., Vaskó, A., Szabó, Z., Bácskay, I., Lekli, I., Fésüs, A.: Evaluation of the Diagnosis and Antibiotic Therapy of Sepsis in the Emergency Department: A Retrospective Observational Study.
Biomedicines. 13 (7), 1566, 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

14.

Bodnár, K., Marminon, C., Perret, F., Haimhoffer, Á., Papp, B., Fehér, P., Ujhelyi, Z., Jose, J., Le Borgne, M., Bácskay, I., Józsa, L.: Formulation and Evaluation of Alginate Microcapsules Containing an Uncompetitive Nanomolar Dimeric Indenoindole Inhibitor of the Human Breast Cancer Resistance Pump ABCG2 with Different Excipients.
Pharmaceutics. 17 (12), 1-24, (article identifier: 1587), 2025.

doi DEA

Journal metrics:

D1 Pharmaceutical Science

15.

Papp, B., Józsa, L., Sinka, D. Z., Fidrus, E., Kardos, G., Nacsa, F., Bácskay, I., Fehér, P.: Formulation and investigation of Lactobacillus rhamnosus cek-R1 filled alginate microspheres with different excipients.
DRem. 1 (2), 1-16, 2025.

doi DEA

16.

Bodnár, K., Fehér, P., Ujhelyi, Z., Haimhoffer, Á., Papp, B., Sinka, D. Z., Freytag, C., Fidrus, E., Szarka, K., Kardos, G., Nacsa, F., Bácskay, I., Józsa, L.: Formulation and Testing of Alginate Microbeads Containing Salvia officinalis Extract and Prebiotics.
Pharmaceutics. 17 (10), 1-33, (article identifier: 1308), 2025.

doi DEA WoS Scopus

Journal metrics:

D1 Pharmaceutical Science

17.

Vámosi, B., Bácskay, I., Fehér, P., Arany, P.: Hot-melt extrusion - filament manufacturing coupled with fused deposition modeling for 3D printed pharmaceuticals: a brief review.
DRem. 1 (2), 17-28, 2025.

doi DEA

18.

Flaskó, A., Fazekas, L., Kincses, G., Varga, Á., Mátrai, Á. A., Czirják, I., Dodity, N., Bácskay, I., Pető, Á., Reglődi, D., Fillér, C., Juhász, T., Németh, N.: Impacts of PACAP 1-38 and BGP-15 on the Healing of Fasciocutaneous Groin Flaps Affected by Ischemia-Reperfusion in Rats.
Biomedicines. 13 (9), 1-18, (article identifier: 2129), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

19.

Baka, J., Papp, E., Angyal, A., Kertész, Z., Bácskay, I.: Investigation of drug exposure during extemporaneous preparation of medicine.
In: Pharmaceutical Sciences in the Heart of Europe / org. by EUFEPS, Universität Wien, Wien, 164, 2025.

DEA

20.

Karetka, A. J., Papp, B., Lekli, I., Vlase, A. M., Pallag, A., Vicaș, L. G., Lestyán, A. M., Józsa, L., Kósa, D., Pető, Á., Ujhelyi, Z., Nacsa, F., Bácskay, I., Fehér, P., Jurca, T.: In Vitro and in Vivo Efficacy of Different Ointment Formulations Containing Centaurium erythraea Rafn. Aerial Extract.
Pharmaceuticals. 18 (11), 1-27, (article identifier: 1681), 2025.

doi DEA

Journal metrics:

Q1 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmaceutical Science

21.

Kósa, D., Pető, Á., Bácskay, I.: Pharmaceutical aspects of conventional and recent developments for the treatment of metabolic diseases and disorders.
In: Pharmacological Targets in Metabolic Diseases. Ed.: by Marcos Roberto de Oliveira, Elsevier, London, 53-62, 2025. ISBN: 9780443273704

DEA

22.

Girgis, M. M. F., Farkasinszky, G., Fekete, K., Fekete, I., Vecsernyés, M., Bácskay, I., Horváth, L.: Sex differences in suspected adverse drug reactions of anti-seizure medications reported in EudraVigilance.
Eur. J. Pharm. Sci. 210, 1-16, (article identifier: 107119), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmaceutical Science

23.

Balogh, B. N., Pető, Á., Fehér, P., Ujhelyi, Z., Bácskay, I.: Tapinarof Nanogels as a Promising Therapeutic Approach.
Pharmaceutics. 17 (6), 1-28, (article identifier: 731), 2025.

doi DEA

Journal metrics:

D1 Pharmaceutical Science

24.

Hermenean, A., Dossi, E., Hamilton, A., Trotta, M. C., Russo, M., Lepre, C. C., Sajtos, C., Rusznyák, Á., Váradi, J., Bácskay, I., Budai, I., D'Amico,, M., Fenyvesi, F.: Chrysin Directing an Enhanced Solubility through the Formation of a Supramolecular Cyclodextrin-Calixarene Drug Delivery System: A Potential Strategy in Antifibrotic Diabetes Therapeutics.
Pharmaceuticals (Basel). 17 (1), 1-20, (article identifier: 107), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Drug Discovery

Q2 Molecular Medicine

Q1 Pharmaceutical Science

25.

Papp, B., Józsa, L., Pető, Á., Kósa, D., Ujhelyi, Z., Pallér, Á., Bácskay, I., Fehér, P.: CK2 inhibitor tartalmú alginát mikrogyöngyök formulálása és vizsgálata különböző segédanyagokkal.
egis. 3 (3), 18-30, 2024.

DEA

Bácskay Ildikó

Publication list